Webinar: Innovative Solvent-free Technology for Oral Bioavailability Enhancement
Catch up with the latest Microfluidics webinar with Skyepharma and LAGEPP.
The session presented how Microfluidizer® technology, through a solvent-free manufacturing process, can help solve bioavailability issues and is particularly suitable for industrial transposition.
The presentation focused on the many factors that limit the effectiveness of oral treatments, including the poor bioavailability of some Active Pharmaceutical Ingredients (API). Due to these issues, particle size reduction and nanoencapsulation of BCS class II or IV API have become innovative strategies to improve drug solubility and also control its release and avoid hepatic first-pass effects.